March 16, 2017 6:21pm
… While maintaining a positive upside; the level of speculation is high as selling pressure slips
Which makes the sector susceptible to weakness as the weekend approaches; it always a question of being too long by a Friday’s close in these times
… Pre-open indications: 3 hit and 2 miss
… Q4/16 financial results: BioTime (NYSEMKT: BTX), Histogenics (HSGX) and Fate Therapeutics (FATE)
The sector is what it is, until it isn’t and even then it doesn’t seem to be…!
Readership is a team sport, are you on it?
Members only. Please login.